ArticleBiomedical optics express2026
Chromatic differential confocal matrix-based 3D topography and hyperspectral imaging with deep learning for osteoarthritis grading.
Article in Biomedical optics express, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate assessment of knee osteoarthritis (KOA) is limited by the current arthroscopy's reliance on subjective visual inspection. We propose a 3D spatio-spectral automatic grading framework combining deep learning with chromatic differential confocal matrix-based 3D topography and hyperspectral imaging (CDCM-THI). Our digital micromirror device-based system simultaneously captures high-resolution 3D micro-topography and hyperspectral cartilage signatures (lateral: 3.91 µm, axial: 1.96 µm, spectral: ∼15 nm). To analyze this multi-modal data, we developed an improved ResNet50 late fusion network optimized with a consistency-enhanced loss function. Evaluated on ex vivo clinical samples, our framework achieved an average cross-validation accuracy of 94.83%, significantly outperforming single-modal baselines. This non-destructive approach bridges the gap between topographical assessment and broadband optical analysis, providing a powerful quantitative tool for future deep learning-assisted arthroscopic integration.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.